Pages that link to "Q41760758"

The following pages link to Cholic acid synthesis as an index of the severity of liver disease in man. (Q41760758):

Displaying 33 items.

• Identification of a new inborn error in bile acid synthesis: mutation of the oxysterol 7alpha-hydroxylase gene causes severe neonatal liver disease (Q24564340) (← links)
• The metabolism of steroids in the fatty liver induced by orotic acid feeding (Q28334236) (← links)
• Sulphated and unsulphated bile acids in serum, bile, and urine of patients with cholestasis (Q28335479) (← links)
• Serum bile acids in the diagnosis of hepatobiliary disease (Q34473665) (← links)
• Modulation of the fecal bile acid profile by gut microbiota in cirrhosis (Q34554908) (← links)
• The use of stable and radioactive sterol tracers as a tool to investigate cholesterol degradation to bile acids in humans in vivo. (Q37985453) (← links)
• Bile acid profile and decrement rate of serum total bilirubin after biliary drainage (Q39513602) (← links)
• Serum bile acids in hepatobiliary disease (Q39762366) (← links)
• Pathophysiology of the enterohepatic circulation of bile acids (Q39791856) (← links)
• Current concepts of the pathogenesis of cholesterol gallstones (Q39948672) (← links)
• Jejunum and bile acid synthesis. Comparison of effects of jejunoileal bypass with 3:1 and 1:3 jejunoileal ratio (Q40249861) (← links)
• Gallstone disease: pathogenesis and management (Q40598896) (← links)
• Clinical pharmacokinetics of therapeutic bile acids. (Q41066462) (← links)
• Serum Levels and Clearance of Bile Acids Are Unaffected by Jejunoileal Bypass with 3:1 or 1:3 Jejunoileal Ratio (Q41640812) (← links)
• Pool size, synthesis, and turnover of sulfated and nonsulfated cholic acid and chenodeoxycholic acid in patients with cirrhosis of the liver (Q42026656) (← links)
• Bile acid metabolism in cirrhosis. VIII. Quantitative evaluation of bile acid synthesis from [7 beta-3H]7 alpha-hydroxycholesterol and [G-3H]26-hydroxycholesterol. (Q42263128) (← links)
• Profiles of serum bile acids in liver diseases (Q42498996) (← links)
• Relative concentrations of individual nonsulfated bile acids in the serum and bile of patients with cirrhosis (Q43518750) (← links)
• Effect of cholestyramine on bile acid kinetics in patients with portal cirrhosis of the liver. Evidence of a selective defect in the formation of cholic acid (Q43610197) (← links)
• Serum concentrations and excretion of bile acids in cirrhosis (Q44690796) (← links)
• Determination of individual serum bile acids in chronic liver diseases: fasting levels and results of oral chenodeoxycholic acid tolerance test. (Q51624875) (← links)
• Decreased insulin binding to red blood cells in liver cirrhosis (Q51646516) (← links)
• Biliary lipid composition in patients with porta cirrhosis of the liver (Q51660508) (← links)
• Radioimmunoassay of serum-conjugated deoxycholic acid (Q51668519) (← links)
• Effect of glucose administration on cholesterol and bile acid metabolism in rats (Q51672942) (← links)
• Diagnosis of hepatocellular carcinoma using a novel anti-glycocholic acid monoclonal antibody-based method (Q64234136) (← links)
• Studies on biliary bile acid metabolism in hepato-biliary diseases (Q67398254) (← links)
• Bile-acid metabolism and the liver (Q67461985) (← links)
• Characteristics of biliary lipid metabolism after liver transplantation (Q68583683) (← links)
• [Pathogenic significance of bile acids (author's transl)] (Q70835205) (← links)
• Serum, fecal and urinary bile acids in patients with mild and advanced liver cirrhosis (Q71065168) (← links)
• Selectivity and sensitivity of changes in serum bile acids during induction of cirrhosis in rats (Q72567648) (← links)
• Cholic acid synthesis is reduced in pediatric liver recipients during graft dysfunction due to ischemic injury and allograft rejection (Q73987338) (← links)